Lumiera Health (TSXV:NHP.H) EBIT: C$-1.30 Mil (TTM As of Aug. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lumiera Health EBIT?

Lumiera Health TSXV:NHP.H EBIT is C$-1.30 Mil as of Aug. 2023.

Lumiera Health's earnings before interest and taxes (EBIT) for the three months ended in Aug. 2023 was C$-0.06 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Aug. 2023 was C$-1.30 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Lumiera Health's annualized ROC % for the quarter that ended in Aug. 2023 was -19.67%. Lumiera Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -10,080.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Lumiera Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -51.67%.

Lumiera Health  (TSXV:NHP.H) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Lumiera Health's annualized ROC % for the quarter that ended in Aug. 2023 is calculated as:

ROC % (Q: Aug. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Aug. 2023 ))/ count )
=-0.248 * ( 1 - 0% )/( (1.186 + 1.335)/ 2 )
=-0.248/1.2605
=-19.67 %

where

Invested Capital(Q: May. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.282 - 0.312 - ( 0.018 - max(0, 1.385 - 0.169+0.018))
=1.186

Invested Capital(Q: Aug. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.253 - 0.332 - ( 0.013 - max(0, 1.557 - 0.143+0.013))
=1.335

Note: The Operating Income data used here is four times the quarterly (Aug. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Lumiera Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Aug. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: May. 2023  Q: Aug. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.252/( ( (0.003 + max(-0.168, 0)) + (0.002 + max(-0.506, 0)) )/ 2 )
=-0.252/( ( 0.003 + 0.002 )/ 2 )
=-0.252/0.0025
=-10,080.00 %

where Working Capital is:

Working Capital(Q: May. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.02 + 0.12 + 0.004) - (0.312 + 0 + 0)
=-0.168

Working Capital(Q: Aug. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.027 + 0.082 + 0.012) - (0.332 + 0.295 + 0)
=-0.506

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Aug. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Lumiera Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Aug. 2023 )
=-1.301/2.518
=-51.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumiera Health EBIT Related Terms

Lumiera Health EBIT Historical Data

* Premium members only.

The historical data trend for Lumiera Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumiera Health EBIT Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.44 -1.68 -1.77 0.38 -1.97

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -1.17 -0.02 -0.05 -0.06

TSXV:NHP.H vs ZTS, CTLT, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumiera Health EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lumiera Health's EV-to-EBIT falls into.


Lumiera Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of C$-1.30 Mil mean?
Lumiera Health (TSXV:NHP.H) has a EBIT of C$-1.30 Mil as of Aug. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Lumiera Health.
Is Lumiera Health's EBIT too high?
Lumiera Health's current EBIT is C$-1.30 Mil.
How does Lumiera Health's EBIT compare to ZTS and CTLT?
Lumiera Health's EBIT of C$-1.30 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Lumiera Health. Lumiera Health's current EBIT is C$-1.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumiera Health stock overvalued right now?
Lumiera Health (TSXV:NHP.H) has a current EBIT of C$-1.30 Mil. The current EBIT is C$-1.30 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Lumiera Health (TSXV:NHP.H), the current EBIT is C$-1.30 Mil as of Aug. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumiera Health Business Description

Address 4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc operates as a product development, marketing and sales business of natural products that outsources the manufacturing of products to third-party manufacturing partners/suppliers. The company sells natural and homeopathic products as well as the development and commercialization of botanical-based products for low-risk agricultural use and human health care.